Génome Québec invests up to $500,000 to boost Ï㽶ÊÓƵ therapeutics innovation in Quebec
Génome Québec, a private, non-profit organization dedicated to advancing genomics research and innovation in Quebec, is investing up to $500,000 in Ï㽶ÊÓƵ’s D2R Initiative. This investment will advance the commercialization of innovative genomic technologies in Quebec through D2R’s Commercialization Priming funding program.